Cell Cycle Analysis Market Research Report – Forecast to 2027

Cell Cycle Analysis Market: Information by Product (Consumables, Instruments, & Others), Application (Cell Identification and Others), End-User (Academics & Research Institutions, Hospitals & Diagnostic Laboratories, & Others) – Global Forecast Till 2027

ID: MRFR/LS/0202-HCR | February 2021 | Region: Global | 85 pages

Please note that the assessment period of report has been updated from 2018-2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Scenario

The cell cycle analysis market is expected to show a prominent growth during the forecast period (2018–2023).

Cell cycle analysis products are used in numerous life science research activities as well as in biomedical research and clinical research laboratories. Cell cycle analysis is carried out to check the effects of various internal and external factors on cells. Increasing expenditure on cell level research by the corporate sector, government initiatives for cell research, increasing chronic genetic diseases, rising occurrence of cell-specific diseases, and cancer and aggressive strategies by market players are expected to drive the growth of the market. For instance, In March 2018, Agilent technologies which is one of the major players in the cell cycle analysis market acquired advanced analytical technologies for USD 250 million.

The high costs of cell analysis instruments and expensive maintenance might be a problem for small research groups and it can hamper the growth of the market during the assessment period.

Cell Cycle Analysis Market Segmentation

The cell cycle analysis market has been segmented on the basis of product, application, and end-user.

On the basis of product, the market has been classified as consumables and instruments. The consumables segment has been further divided into reagents, assay kits, microplates, and other consumables. The assay kits segment has been further divided into immunoassay and cell-based assay. The instruments segment has been classified into microscopes, flow cytometry, spectrophotometer, qPCR, cell counter, high content screening systems, and cell microarrays. The microscopes segment has been divided into electron microscopes, inverted microscopes, stereomicroscopes, fluorescence and confocal microscopes, phase contrast microscopes, Near-Field Scanning Optical Microscopes (NSOM), and other microscopes. The flow cytometers sub-segment has been segmented into flow cytometry instruments and flow cytometry software. The spectrophotometers segment has been divided into fluorescence microplate readers, microplate spectrophotometers, and colorimeters. Furthermore, cell counters have been sub-segmented into automated cell counters and hemocytometers and manual cell counters. The synthetic High-Content Screening (HCS) systems segment includes cell imaging and analysis HCS systems and HCS software.

The market, by application, has been segmented into cell identification, cell viability, cell signaling pathway/signal transduction, cell proliferation, cell counting and quality control, cell interaction, cell structure study, target identification, and validation and single-cell analysis.

Based on end-user, the market has been divided into, academics and research institutions, hospitals and diagnostic laboratories, pharmaceuticals (CROs and biotechnology companies), and other end-users.

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The cell cycle analysis market in the Americas has further been segmented into North America and South America, with the North American market is divided into the US and Canada.

The European cell cycle analysis market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The cell cycle analysis market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The cell cycle analysis market in the Middle East & Africa has been segmented into the Middle East and Africa.

Regional Market Summary

Cell Cycle Analysis Market Share, by Region, 2017 (%)

Cell Cycle Analysis Market Share

Source: MRFR Analysis

The Americas are likely to dominate the cell cycle analysis market owing to the presence of well-established research and development facilities, government funding to encourage cell level research and development, and rising prevalence of cancer. According to the National Cancer Institute, in 2016, 15.5 million cancer cases were found in the US. The expenditure on cancer care in 2017 was USD 147.3 billion.

The European market is expected to be the second-largest cell cycle analysis market. The market growth in this region can be attributed to the adoption of highly advanced technology. Moreover, a growing number of life sciences and medical research institutes in Europe is contributing to the growth of the market in this region.

Asia-Pacific is expected to be the fastest-growing cell cycle analysis market during the forecast period owing to the rising investments in life science and healthcare research and government support and favorable policies for the research sector.

The market in the Middle East and Africa is expected to account for the smallest share of the cell cycle analysis market due to an underdeveloped research sector, lack of technical knowledge, and poor research and development facilities.

Company Profiles

Becton, Dickinson and Company

Merck & Co., Inc.

Thermo Fisher Scientific, Inc.

Danaher Corporation

GE Healthcare

Agilent Technologies, Inc.

Olympus Corporation

PerkinElmer, Inc.

Promega Corporation

Bio-Rad Laboratories, Inc.

Miltenyi Biotech

Nexcelom Bioscience LLC.

Cell Cycle Analysis Market, by Product

Consumables

Reagents

Assay Kits

Immunoassays

Cell-Based Assays

Microplates

Other Consumables

Instruments

Microscopes

Electron Microscopes

Inverted Microscopes

Stereomicroscopes

Fluorescence and Confocal Microscopes

Phase Contrast Microscopes

Near-field Scanning Optical Microscopes (NSOM)

Other Microscopes

Flow Cytometers

Flow Cytometry Instruments

Flow Cytometry Software

Spectrophotometers

Fluorescence Microplate Readers

Microplate Spectrophotometers

Colorimeters

qPCR

Cell Counters

Automated Cell Counters

Hemocytometers and Manual Cell Counters

High-content screening (HCS) Systems

Cell Imaging and Analysis HCS Systems

HCS Software

Cell Microarrays

Cell Cycle Analysis Market, by Application

Cell Identification

Cell Viability

Cell Signaling Pathway/Signal Transduction

Cell Proliferation

Cell Counting and Quality Control

Cell Interaction

Cell Structure Study

Target Identification and Validation

Single-Cell Analysis

Cell Cycle Analysis Market, by End-User

Academics & Research Institutions

Hospitals and Diagnostic Laboratories

Pharmaceuticals- CROs and Biotechnology Companies

Other End-Users

Cell Cycle Analysis Market, by Region

Americas

North America

Canada

South America

Europe

Western Europe

Germany

France

Italy

Spain

Rest of Western Europe

Eastern Europe

Asia-Pacific

Japan

China

India

Australia

South Korea

Rest of Asia-Pacific

Middle East & Africa

Middle East

Africa

Intended Audience

Cell cycle analysis instrument manufacturers

Cell cycle analysis consumables manufacturers

Cell cycle analysis product distributors and suppliers

Healthcare providers and diagnostic centers

Medical device manufacturers

Research institutes and academic centers

Contract Research Organizations (CROs)

Government associations

Market research and consulting

Frequently Asked Questions (FAQ) :

Name major drivers of the global cell cycle analysis market?

Need for anticancer treatment, increased expenditure on cell research, and rising incidence of chronic diseases are major drivers of the global cell cycle analysis market.

Which region registered the largest share in the global cell cycle analysis market?

The Americas have registered the largest share in the global cell cycle analysis market due to presence of research and development facilities.

Which region has assumed the second position in the global cell cycle analysis market?

Europe is the second largest in the global cell cycle analysis market due to establishment of research institutes and life science companies.

Name the biggest players of the global cell cycle analysis market?

Miltenyi Biotech, Promega Corporation, Danaher Corporation, Nexcelom Bioscience LLC., Becton, Dickinson and Company, Agilent Technologies, Inc., GE Healthcare, Olympus Corporation, Merck & Co., Inc., PerkinElmer, Inc., Bio-Rad Laboratories, Inc., and Thermo Fisher Scientific, Inc. are major players of the global cell cycle analysis market.

Which strategies are being incorporated by players in the global cell cycle analysis market?

Acquisitions are the major strategy being incorporated by players in the global cell cycle analysis market.

Table of Contents

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Cell Cycle Analysis Market, by Product

6.1 Introduction

6.2 Consumables

6.2.1 Reagents

Market Estimates & Forecast, by Region, 2020-2027